Discontinued — last reported Q1 '19
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Investment Management | 188,500,000,000% | 220,200,000,000% | — | 198,400,000,000% | 209,000,000,000% | 204,200,000,000% | — | 217,500,000,000% |
| Institutional Securities | — | — | 51% | — | — | — | 51% | — |
| Total | — | — | — | — | — | — | — | — |
Institutional Securities was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.